Form 4: Tandem Diabetes Care Executive Reports Stock Transactions

Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent withholding of shares for tax obligations.

Summary

• On March 17, 2025, Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, reported transactions involving the company's stock.
• Carpenter acquired 406 shares of common stock upon the vesting of restricted stock units (RSUs) at a price of $0.
• Simultaneously, 146 shares were withheld by Tandem Diabetes Care to satisfy tax obligations related to the RSU vesting at a price of $19.17.
• Following these transactions, Carpenter directly owns 16,392 shares of Tandem Diabetes Care common stock and 1,218 restricted stock units.
• The RSUs were awarded on December 15, 2021, under the company's 2013 Stock Incentive Plan and vest in installments.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions related to executive compensation. The vesting of RSUs could be seen as a slightly positive indicator, but the tax withholding is a neutral event.

Positives

• The vesting of RSUs indicates that performance milestones were likely met, which is a positive sign.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company executives and their confidence in the company's future prospects.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
• Vesting schedules and tax withholding practices are standard across publicly traded companies.
• Comparable companies like Insulet (PODD) and Dexcom (DXCM) also have executives who regularly report similar transactions.

Stakeholder Impact

• The transactions have a minimal direct impact on shareholders, employees, customers, suppliers, or creditors.
• The disclosure provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates

Keywords

Tandem Diabetes Care, Rick Carpenter, stock transaction, Form 4, restricted stock units, RSU, insider trading, TNDM